Contraceptive effectiveness of Silastic implants containing the progestin R-2323.
D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced; D002214:Capsules; D003267:Contraception; D004341:Drug Evaluation; D004343:Drug Implants; D005260:Female; D006801:Humans; D008599:Menstruation Disturbances / Q000139:chemically induced; D009645:Norgestrienone / Q000031:analogs & derivatives; D009651:Norpregnatrienes / Q000008:administration & dosage* / Q000009:adverse effects; D010298:Parity; D011247:Pregnancy; D045167:Progesterone Congeners / Q000008:administration & dosage* / Q000009:adverse effects; D012826:Silicone Elastomers; D013997:Time Factors
D002214:Capsules; D004343:Drug Implants; D009651:Norpregnatrienes; D045167:Progesterone Congeners; D012826:Silicone Elastomers; D009645:Norgestrienone